Why it matters: internal audits prove whether your quality system is operating rather than just documented.
Internal audits are the evidence that your quality system knows its own gaps.
Internal audit expectations appear across GMPs and guidance:
Regulatory callout: regulators expect internal audits to include findings, root-cause analysis, and follow-up evidence.
Inspectors assess whether internal audits are complete and effective:
Inspector insight: repeating findings signal weak audits rather than just poor execution.
Common pitfalls include:
Failure callout: if audits only regurgitate old reports, inspectors see them as a waste of time.
A modern eQMS boosts internal audit value:
Complere keeps audit evidence connected so managers can show auditors the full path from finding to improvement.
Complere tracks findings inside the same platform as deviations, CAPA, change control, and documents so auditors can show the full path from discovery to verification.
Inspectors expect risk-based audit plans, documented findings, timely follow-up, and records showing how leadership used the results.
FDA, EU GMP, PIC/S, and ICH Q10 require periodic internal audits as part of a robust pharmaceutical quality system.
Internal audits are proactive self-inspections with documented follow-up, while regulators verify whether those internal checks were effective.
Internal audit validates whether controlled processes are operating as designed, identifying weaknesses before regulators do.
Complere helps regulated teams run internal audits with stronger visibility over findings, evidence, due dates, and the follow-up activity that makes the program defensible.
Audit ready | Stronger finding control | Better follow-through
